Related Experiment Video
Updated: Mar 26, 2026
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
15.3K
[Medication Therapy for Soft Tissue Sarcoma (Current Status and Future Perspective)]
1Dept. of Clinical Oncology, Aichi Cancer Center Hospital.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|January 27, 2016
Abstract:
Doxorubicin and ifosfamide have played a major role in the medical therapy for soft tissue sarcoma (STS). In the last few years, new cytotoxic drugs (eribulin, trabectedin, etc.) and molecular targeting drugs(pazopanib, which is a tyrosine kinase inhibitor of VEGFR1-3, and PDGFR) have been introduced in clinical practice for the treatment of STS. These new drugs are expected to improve the outcome of medical therapy for STS in the future.
Insights
Doxorubicin and ifosfamide are standard treatments for soft tissue sarcoma (STS). Newer drugs, including cytotoxic and targeted therapies, offer improved outcomes for STS patients.
Area of Science:
- Oncology
- Medical Therapy
Context:
- Soft tissue sarcoma (STS) treatment has historically relied on doxorubicin and ifosfamide.
- Recent advancements have introduced novel therapeutic agents into clinical practice.
Purpose:
- To review the evolving landscape of medical therapy for soft tissue sarcoma.
- To highlight the introduction and potential impact of new cytotoxic and molecularly targeted drugs.
Summary:
- Doxorubicin and ifosfamide remain key chemotherapeutic agents for STS.
- Newer drugs like eribulin, trabectedin, and pazopanib (a tyrosine kinase inhibitor targeting VEGFR and PDGFR) are now available.
- These agents represent significant progress in STS treatment options.
Impact:
- The introduction of novel cytotoxic and targeted therapies is anticipated to enhance treatment efficacy for STS.
- Future outcomes in medical therapy for STS are expected to improve with these advanced drug options.
Related Concept Videos
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
01:15Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:28Drug Therapy
392
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
392
01:27Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K